Riecken EO - Search Results

1

Drug therapy in metastatic neuroendocrine tumors of the gastroenteropancreatic system.

Faiss S, Scherübl H, Riecken EO, Wiedenmann B. Faiss S, et al. Among authors: riecken eo. Recent Results Cancer Res. 1996;142:193-207. doi: 10.1007/978-3-642-80035-1_12. Recent Results Cancer Res. 1996. PMID: 8893342 Review.

2

Somatostatin-receptor imaging of neuroendocrine gastroenteropancreatic tumors.

Scherübl H, Bäder M, Fett U, Hamm B, Schmidt-Gayk H, Koppenhagen K, Dop FJ, Riecken EO, Wiedenmann B. Scherübl H, et al. Among authors: riecken eo. Gastroenterology. 1993 Dec;105(6):1705-9. doi: 10.1016/0016-5085(93)91066-q. Gastroenterology. 1993. PMID: 7902821

3

[Significance of false-positive findings of somatostatin receptor scintigraphy in diagnosis of neuroendocrine tumors of the gastroenteropancreatic system].

Faiss S, Scherübl H, Bäder M, Fett U, Koppenhagen K, Wiedenmann B, Riecken EO. Faiss S, et al. Among authors: riecken eo. Z Gastroenterol. 1994 May;32(5):243-6. Z Gastroenterol. 1994. PMID: 7915450 German.

4

New molecular aspects for the diagnosis and treatment of neuroendocrine gastroenteropancreatic tumors.

Wiedenmann B, Ahnert-Hilger G, Kvols LK, Riecken EO. Wiedenmann B, et al. Among authors: riecken eo. Ann N Y Acad Sci. 1994 Sep 15;733:515-25. doi: 10.1111/j.1749-6632.1994.tb17302.x. Ann N Y Acad Sci. 1994. PMID: 7978902 Review. No abstract available.

5

Gastroenteropancreatic tumor imaging with somatostatin receptor scintigraphy.

Wiedenmann B, Bäder HM, Scherubl H, Fett U, Zimmer T, Hamm B, Koppenhagen K, Riecken EO. Wiedenmann B, et al. Among authors: riecken eo. Semin Oncol. 1994 Oct;21(5 Suppl 13):29-32. Semin Oncol. 1994. PMID: 7992077 No abstract available.

6

The ultimate biochemical diagnosis of neuroendocrine gastro-enteropancreatic tumours.

Faiss S, Scherübl H, Riecken EO, Wiedenmann B. Faiss S, et al. Among authors: riecken eo. Digestion. 1996;57 Suppl 1:48-9. doi: 10.1159/000201395. Digestion. 1996. PMID: 8813469 Review.

7

Interferon-alpha versus somatostatin or the combination of both in metastatic neuroendocrine gut and pancreatic tumours.

Faiss S, Scherübl H, Riecken EO, Wiedenmann B. Faiss S, et al. Among authors: riecken eo. Digestion. 1996;57 Suppl 1:84-5. doi: 10.1159/000201404. Digestion. 1996. PMID: 8813478

8

Molecular and cell biological aspects of neuroendocrine tumors of the gastroenteropancreatic system.

Wiedenmann B, John M, Ahnert-Hilger G, Riecken EO. Wiedenmann B, et al. Among authors: riecken eo. J Mol Med (Berl). 1998 Aug;76(9):637-47. doi: 10.1007/s001090050261. J Mol Med (Berl). 1998. PMID: 9725766 Review.

9

Ultra-high-dose lanreotide treatment in patients with metastatic neuroendocrine gastroenteropancreatic tumors.

Faiss S, Räth U, Mansmann U, Caird D, Clemens N, Riecken EO, Wiedenmann B. Faiss S, et al. Among authors: riecken eo. Digestion. 1999 Sep-Oct;60(5):469-76. doi: 10.1159/000007693. Digestion. 1999. PMID: 10473972

10

Endoscopic ultrasonography of neuroendocrine tumours.

Zimmer T, Scherübl H, Faiss S, Stölzel U, Riecken EO, Wiedenmann B. Zimmer T, et al. Among authors: riecken eo. Digestion. 2000;62 Suppl 1:45-50. doi: 10.1159/000051855. Digestion. 2000. PMID: 10940687

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

433 results

Search Page

Filters